MedPath
NMPA Approval

Isoprenaline Hydrochloride Injection

国药准字H20244011

June 11, 2024

Drug Information

盐酸异丙肾上腺素注射液

注射剂

1ml∶0.2mg

化学药品

June 11, 2024

Company Information

Applicant Company

成都高新区冯家湾工业园科园南路88号B7栋5楼

Manufacturing Company

峨眉山市加工仓储物流园通惠路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸异丙肾上腺素注射液 - NMPA 批准文号 | MedPath